Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Kåre Schultz - President & CEO at Teva Pharmaceutical Industries | The Org
Teva denies outgoing CEO board role
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Serial Problem Solver
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva names Lundbeck's Kåre Schultz as President and Chief Executive Officer - PharmaTimes
A Look At Kare Schultz, The New CEO In Charge Of Teva
Watch CNBC's full interview with Teva CEO Kåre Schultz
Cephalon's CEO vs Kåre Schultz | Comparably
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Lundbeck CEO Kåre Schultz comments on Lundbeck's 2017 H1 Results - YouTube
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Serial Problem Solver
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the
Teva CEO steps down, replacement found
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Investors Are Back on the Rollercoaster | Ctech
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva names Kåre Schultz as new CEO
